East Brunswick, NJ, United States of America

Guodong Chen

This inventor holds 41 USPTO granted patents and 20 published patent applications and 10 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Bristol-Myers Squibb Compnay, Five Prime Therapeutics, Inc.. Active years: 2015-2025.

USPTO Granted Patents = 41 (Patent Applications = 20)

% Patents Active = 100.0

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 10.2

ph-index = 7

Forward Citations = 130(Granted Patents)

Location History:

East Brunswick, NJ (US) (2015 - 2024)
Princeton, NJ (US) (2024)

Company Filing History:

41 out of 3,735

Bristol-Myers Squibb Compnay

patents

4 out of 77

Five Prime Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Antibodies

TIM3

GITR

NKG2A

IL-7R

TREM-1

HLA-E

Cancer Treatment

Inflammation

Bispecific Antibodies

Diagnostics

Scaffold Molecules

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435136 - Antibodies binding to ILT4 (2025-10-07),

2. 12312403 - Antibodies against TIM3 and uses thereof (2025-05-27),

3. 12173069 - Antibodies binding to vista at acidic pH (2024-12-24),

4. 12129297 - Antibodies against TIM3 and uses thereof (2024-10-29),

5. 12110337 - Anti-CD27 antibodies and uses thereof (2024-10-08),

6. 12091462 - Antibodies binding to vista at acidic pH (2024-09-17),

7. 12077584 - Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A) (2024-09-03),

8. 11981734 - Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A) (2024-05-14),

9. 11952420 - Nucleic acids encoding anti-TREM-1 antibodies (2024-04-09),

10. 11919962 - Antibodies against IL-7R alpha subunit and uses thereof (2024-03-05),

11. 11919954 - Anti-TREM-1 antibodies and uses thereof (2024-03-05),

12. 11802162 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2023-10-31),

13. 11767364 - TL1A antibodies and methods of treatment (2023-09-26),

14. 11708405 - IP-10 antibodies and their uses (2023-07-25),

15. 11591392 - Antibodies against TIM3 and uses thereof (2023-02-28),

Title: The Innovative Journey of Guodong Chen

Introduction: Guodong Chen, a talented inventor hailing from East Brunswick, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Guodong Chen's latest patents include groundbreaking inventions in the field of renewable energy storage systems and advanced medical devices.

Career Highlights: With a career spanning over two decades, Guodong Chen has worked tirelessly to develop cutting-edge solutions in various industries, ranging from electronics to healthcare. His innovative spirit and dedication have led to numerous successful patents and inventions.

Collaborations: Throughout his career, Guodong Chen has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Guodong Chen's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.